Clinverse, Inc. Exhibiting and Showcasing Automated Clinical Trial Financial Technology at DIA 2014

Share Article

Clinverse Architected the New Standard for Clinical Trial Finance Through Improved Time, Cost and Resource Efficiencies for Sponsors and CROs

News Image

Clinverse, Inc., provider of the first end-to-end technology solution for automating the financial lifecycle of global clinical trials, announced it will be exhibiting and showcasing its automated investigator payment solutions at booth #2432 at DIA (Drug Information Association) 2014 50th Annual Meeting in San Diego, June 16-18, 2014.

Clinverse helps sponsors and CROs reduce workload and costs while improving transparency and control. Clinverse’s flagship product, ClinPay®, is designed to automate the entire financial lifecycle of global clinical trials. From the initial site contract through to the payment of investigative sites, ClinPay automates the entire process while managing all GAAP accounting and providing in-depth reporting and transparency throughout the life of the trial. ClinDebit® provides the ability for clinical trial subjects to be compensated quickly and efficiently with pre-funded debit cards through an online software application.

DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. This annual meeting provides thought leaders, decision-makers and patient advocates with the opportunity to collaborate and share knowledge with the top minds in medicine.

To schedule a time to meet with a Clinverse team member and learn more about our full suite of clinical trial financial lifecycle technology while at DIA 2014, please call 1.877.325.1122 or email info(at)clinverse(dot)com.

About Clinverse, Inc.
Clinverse, Inc. architected the industry’s first end-to-end technology solution that automates the financial lifecycle of global clinical trials. Powered by our secure technology platform, our solution standardizes clinical trial finance and manages millions of financial transactions across the globe, including clinical site payments. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs gained through automation and unprecedented transparency and workflow. For more information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cassandra Zink

Jennifer Plumer
Visit website